Telix dips as pharma giant abandons US IPO for NASDAQ listing – despite record run
International plans for Telix – proudly boasting its intentions to list on the NASDAQ for a while now – have come to an anticlimactic end.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SHU | Ann: Removal from Official List | 03/02/20 | 0 | 773 | |||
|
|||||||
SHU | Ann: Suspension from Official Quotation - Annual Listing Fee | 22/08/19 | 0 | 2.0K | |||
|
|||||||
SHU | Ann: Final Director's Interest Notice | 05/09/18 | 0 | 750 | |||
|
|||||||
SHU | Ann: Director Resignation | 05/09/18 | 0 | 458 | |||
|
|||||||
SHU | Ann: Suspension from Official Quotation - Annual Listing Fees | 22/08/18 | 0 | 843 | |||
|
|||||||
SHU | Ann: Suspension Announcement - System Upgrade | 06/08/18 | 0 | 405 | |||
|
|||||||
SHU | Ann: Suspension from Official Quotation | 02/10/17 | 0 | 518 | |||
|
|||||||
SHU | Ann: Response to ASX Query | 01/09/17 | 0 | 569 | |||
|
See All Discussions